ArticleGlobal medical genetics2026
Toe walking: A regional analysis of TTN variants between c.10,000 and c.99,999 in a cohort of children.
Article in Global medical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Persistent toe walking is traditionally considered idiopathic when no neurological or orthopedic cause is identified. Emerging evidence suggests genetic contributors, including TTN, but genotype-phenotype relationships remain poorly understood in affected children. Methods: This retrospective descriptive study evaluated children with persistent toe walking assessed between November 2022 and April 2026 at a specialized physiotherapy practice. All participants underwent standardized clinical assessment and targeted next-generation sequencing. Individuals carrying TTN variants within the c.10,000-99,999 region were stratified into nine predefined cDNA intervals. Demographic characteristics, gait features, musculoskeletal findings, neurological signs, and variant distributions were summarized descriptively. Results: The cohort comprised 581 individuals carrying 509 TTN variants. Most variants were classified as variants of uncertain significance, while likely pathogenic variants were uncommon. Male predominance was observed across all intervals. Mean age at assessment, age at independent walking, age at toe-walking onset, and toe-walking frequency were highly consistent between groups. Reduced ankle dorsiflexion was the most frequent examination finding, affecting 88.2-97.4% of participants. Muscle pain, cramps, fatigue, spinal abnormalities, heel-walking impairment, pes cavus, tremor, and other associated features demonstrated modest variation across intervals without a consistent regional pattern. Several recurrent TTN variants were identified, most notably c.32624 C>T, c.48727 C>T, and c.73825 G>C. Conclusions: Children carrying TTN variants within the c.10,000-99,999 region exhibited broadly similar clinical phenotypes characterized by persistent toe walking and reduced ankle dorsiflexion. Stratification by cDNA location did not reveal clear genotype-phenotype clustering, suggesting limited predictive value of variant position alone and supporting the need for functional and segregation-based studies in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.